Tom Bourne is Adjunct Professor & Research Team Leader in Dept of Surgery & Cancer, Imperial College London & Visiting Professor, KU Leuven, Belgium. He is Consultant Gynaecologist at Queen Charlotte’s & Chelsea Hospital, London. He is an authority in early pregnancy complications, emergency gynaecology & gynaecological ultrasound.
He has edited 7 books, published >300 papers & been invited to speak at numerous international meetings. His H-index is 44 (Web of Science) & 68 (Google Scholar). He is on the Board & is Treasurer of the International Society for Ultrasound in Obstetrics & Gynecology, President of the Association of Early pregnancy units, & Trustee of the Ectopic Pregnancy Trust. He is chair of the early pregnancy clinical studies group & sits on the research committee at the Royal College of Obstetricians & Gynaecologists. He is on the steering committee of International Ovarian Tumor Analysis trial. He sat on the Society of Radiologists in Ultrasound panel developing guidelines for diagnosing miscarriage in the USA (2012), the American Institute of Ultrasound in Medicine guidelines panel for diagnosing ovarian cancer(2014), and the American College of Radiology committee for ovarian cancer diagnosis(2016).
My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.
More than 14 years experience in mammalian oocytes and pre-implantation embryo development. Created live transgenic cloned goats by somatic cell nuclear transfer (SCNT). Generated several knockout rat and mouse lines by ZFN, TALEN and CRISPR/Cas9.
Currently, I'm a faculty and PI in the University of Massachusetts, Amherst, MA, USA. I am also the Director of Animal Models Core in the Institute for Applied Life Sciences (IALS), Massachusetts, USA.
Academic Editor for PeerJ;
Associate Editor for Journal of Cellular and Molecular Medicine;
Associate Editor for Reproduction and Fertility;
Associate Editor for Animal Reproduction-Theriogenology, Frontiers in Veterinary Science;
Academic Editor for PLOS ONE.
Serve as Peer Reviewer for more than 40 journals and 160 times in the past 7 years.
Keywords: Preimplantation Embryo, Oocyte maturation, CRISPR/Cas9, Knockout, Somatic Cell Nuclear Transfer (SCNT), Oocyte spontaneous activation, Cell cycle, Oocyte aging, Animal models, Epigenetics, Toxicology, Cell culture, Fertilization, Micromanipulation, RNAi, Knockdown, Animal reproduction, Genome editing, Blastocyst, Cell lineage
Dr Martin Daumer: Director of the SLCMSR e.v. - The Human Motion Institute in Munich and managing director of the IT company, Trium Analysis Online GmbH. He is also visiting lecturer for Telemedicine and Clinical Applications of Computational Medicine at the Technical University Munich.
Dr Daumer received a diploma in Physics in 1990 and a Ph.D. in mathematics from the Ludwig-Maximilians-University Munich in 1995, after having worked at CERN, Switzerland, and Rutgers University, USA.
Khalid El Bairi is the founder of The Cancer Biomarkers Working Group, and he is currently pursuing clinical and translational research in medical oncology. He has published many peer-reviewed articles in the field of predictive and prognostic cancer biomarkers to improve survival outcomes in several WoS and Medline-indexed journals. His research focuses particularly on biomarkers for digestive and gynecological cancers such as ovarian and colorectal malignancies. He is currently a member of the board of various international scientific societies such as the International Gynecologic Cancer Society (IGCS), European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Society of Gynaecological Oncology (ESGO), and the American Association for Cancer Research (AACR). He is also an editor and reviewer for more than 40 journals including BMC Cancer, PLoS ONE and Frontiers in Oncology and a guest editor for several special issues on gynecological cancers including Seminars in Cancer Biology and Current Drug Targets. He is also highly interested in teaching evidence-based medicine, clinical research methods, and publishing ethics to medical and Ph.D students and was selected for the 70th Lindau Nobel Laureate Meeting as a young scientist.
Professor, Director of maternity "D" Department and Obstetrical Day care Center , Soroka University Medical Center,Faculty of Health Science, Ben Gurion University of The Negev, Israel. Research Areas: Hypertension In Pregnancy, Coagulation and Hemostasis In Normal and Complicated Pregnancies, Preterm Labor, preterm PROM, IUGR, Stillbirth.
The Development of therapeutic modalities in the field of preterm labor and preeclampsia.
Associate Professor of Obstetrics and Gynecology of the University of Milan-Bicocca, in Monza, Italy and staff physician in the general Gynecological Unit of San Gerardo Hospital. Before MD graduation and during the residency in Obstetrics and Gynecology he conducted an intense preclinical research activity at Mario Negri Institute (Milan) and at Massachusetts General Hospital (Boston). In 2010 he acquired a PhD in Gynecologic Oncology. His research interests are focused on molecular biology of ovarian cancer, and on prevention and treatment of gynecological malignancies.
2001: Degree in Medicine and Surgery
2006: Specialization in Obstetrics and Gynecology
2010: PhD in Gynecologic Oncology
2014: Associate Professor in Obstetrics and Gynecology
Former Professor of Gynecology and Obstetrics. Former Director of the Department of Obstetrics and Gynecology of the University of Pisa. President of the International Society of Gynecological Endocrinology. President of the European Society of Gynecology, Former President of the International Menopause Society. Editor-in-Chief of Gynecological and Reproductive Endocrinology and Metabolism.
Takeshi Kurita, PhD, is an Associate Professor of Cancer Biology and Genetics, at Ohio State University. He is a member of the OSUCCC – James, Cancer Biology Program. Dr. Kurita's research explores the molecular mechanisms of development and disease of the reproductive organs.
Dr. Jinhui Liu, PhD is an attending physician within the Department of Gynecology at The First Affiliated Hospital of Nanjing Medical University (2020 - current). He obtained his PhD in Obstetrics and Gynecology, and Bachelors degree in Clinical Medicine from Nanjing Medical University.
Dr Jinhui Liu's research Interests include:
1.Mechanism of non-coding RNA in Gynecological tumors
2. Prognostic assessment of patients with Gynecological tumors
3. Identification of novel biomarkers for diagnosis and prognosis
4.Genetics, genomics and epigenetics
Dr. Salvatore Andrea Mastrolia completed his degree in Medicine and Surgery with Honors in 2010. He was a resident at the Department of Obstetrics and Gynecology at the University Hospital of Bari "Aldo Moro", Bari (Italy). In 2013, he started his fellowship within the International Fellowship Program for Advanced Training in Obstetrics and Gynecology at the Department of Obstetrics and Gynecology of Soroka University Medical Center (Ben Gurion University of the Negev, Beer Sheva, Israel), which he completed in 2016, focusing on fetal medicine, obstetric ultrasound and management of obstetrical emergencies.
In March 2017, Dr. Mastrolia became a senior physician at the Fondazione MBBM (San Gerardo Hospital, Monza, Italy), an institution dedicated to perinatal medicine and affiliated to the University of Milano Bicocca (Milano, Italy).
HIs research Interests include preterm parturition, preeclampsia, recurrent pregnancy loss, intrauterine growth restriction, fetal demise, premature rupture of membranes, placental abruption, and antithrombotic therapies during pregnancy.
Dr. Salas-Huetos obtained his Bachelor of Science (Biology) from the Universitat de Girona (UdG) in 2009, his MSc in Cell Biology in 2010 at the Universitat Autònoma de Barcelona (UAB), and his Ph.D. in Cell Biology (Cum-Laude and Extraordinary Doctorate Award) in 2016 at the same University (UAB). He joined the Genetics of Male Fertility group (UAB) as a PhD Student, and Human Nutrition Unit (Universitat Rovira i Virgili; URV) in 2016 as a Post-doctoral Fellowship. He spent a three-month Post-doctoral stay (September-December 2017) at Universidad de Guadalajara in Mexico. In 2018, he joined the University of Utah (USA) and in 2020 the Harvard T.H. Chan School of Public Health (Harvard University; USA) as a Post-doctoral Fellow. Nowadays he is a Visiting Scholar at Harvard University for the Department of Nutrition, Harvard T.H. Chan School of Public Health and a Post-doctoral Fellow at Universitat de Girona (JdlCI). Currently, he is working on different large international multicentric projects related to genetics and epigenetics of male (in)fertility, and nutrition. The main contributions of his scientific activity are reflected in a total of 63 original articles (Q1: 51/63; first or corresponding author: 23/63) in SCI/JCR-journals (+ 5 submitted), and 3 book chapter (+2 submitted). He has attended 9 national/international conferences as invited (plenary) speaker and he was the leading author of 10 contributions in international conferences (+15 as a collaborator author).